Tandem Diabetes Care Gets FDA OK for Smallest Durable Insulin Delivery System
11 Julio 2023 - 8:49AM
Noticias Dow Jones
By Ben Glickman
Tandem Diabetes Care said Tuesday the U.S. Food and Drug
Administration cleared its Tandem Mobi insulin pump for people with
diabetes age six and older.
The San Diego-based diabetes technology company said the Tandem
Mobi, a miniature insulin pump controllable from a mobile app, is
the world's smallest durable insulin-delivery system. Tandem said
it expected a limited release of the product in late 2023, and full
commercial availability by early 2024.
Tandem said the new product features a 200-unit insulin
cartridge, and is small enough to fit in a coin pocket. The product
uses Tandem's Control-IQ technology, an algorithm which deliveries
regular insulin deliveries and predicts glucose levels.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
July 11, 2023 09:34 ET (13:34 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Tandem Diabetes Care (NASDAQ:TNDM)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Tandem Diabetes Care (NASDAQ:TNDM)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
